Clinical implications of chromosomal abnormalities in gastric adenocarcinomas

Genes Chromosomes and Cancer

Volumn 35, Issue 3, 2002, Pages 219-231

  Wu, Chew Wun ^a,b   Chen, Gen Der ^c   Fann, Cathy S J ^b,c   Lee, Anna F Y ^a,b   Chi, Chin Wen ^a,b   Liu, Jacqueline M ^d   Weier, Ulli ^e   Chen, Jeou Yuan ^b,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 6P; CHROMOSOME 7P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENETIC ASSOCIATION; GENETIC SELECTION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036836510     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10106     Document Type: Article

References (53)

1. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo W-L, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146.
2. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioneimi O-P, Trent JM, Meltzer PS. 1997. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968.
3. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340:1954-1961.
4. Brinkmann U. 1998. CAS, the human homologue of the yeast chromosome-segregation gene CSE1, in proliferation, apoptosis, and cancer. Am J Hum Genet 62:509-513.
5. Brito MJ, Filipe MI, Williams GT, Thompson H, Ormerod MG, Titley J. 1993. DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases. Gut 34:230-234.
6. Chen Y-J, Ko J-Y, Chen P-J, Shu C-H, Hsu M-T, Tsai S-F, Lin C-H. 1999. Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 25:169-175.
7. Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA. 1999. Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 26:304-311.
8. Dos Santos NR, Seruca R, Constancia M, Seixas M, Sobrinho-Simoes M. 1996. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 110:38-44.
9. El-Rifai W, Harper JC, Cummings OW, Hyytinen E-R, Frierson HF, Knuutila S, Powell SM. 1998. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocaminomas. Cancer Res 58:34-37.
10. Guan XY, Fang Y, Sham JS, Kwong DL, Zhang Y, Liang Q, Li H, Zhou H, Trent JM. 2000. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 29:110-116.
11. Han K, Oh EJ, Kim YS, Kim YG, Lee KY, Kang CS, Kim BK, Kim WI, Shim SI, Kim SM. 1996. Chromosomal numerical aberrations in gastric carcinoma: analysis of eighteen cases using in situ hybridization. Cancer Genet Cytogenet 92:122-129.
12. Inoue F, Uchino S, Shiraishi N, Adachi Y, Kitano S. 1998. Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res 4:973-977.
13. Islam A, Kageyama H, Takada N, Kawamato T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A. 2000. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623.
14. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumor. Genes Chromosomes Cancer 10:231-243.
15. Kihana T, Tsuda H, Hirota T, Shimosato Y, Sakamoto H, Terada M, Hirohashi S. 1991. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 82:308-314.
16. Kim J-H, Takahashi T, Chiba I, Park J-G, Birrer MJ, Roh JK, Lee HD, Kim J-P, Minna JD, Gazdar AF. 1991. Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines. J Natl Cancer Inst 83:938-943.
17. Knuutila S, Armengol G, Bjorkqvist A-M, El-Rifai W, Larramendy ML, Monni O, Szymanska J. 1998a. Comparative genomic hybridization study on pooled DNAs from tumors of one clinical-pathological entity. Cancer Genet Cytogenet 100:25-30.
18. Knuutila S, Bjorkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius V-M, Vidgren V, Zhu Y. 1998b. DNA copy number amplifications in human: review of comparative genomic hybridization studies. Neoplasms. Am J Pathol 152:1107-1123.
19. Kobayashi M, Kawashima A, Mai M, Ooi A. 1996. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. Am J Pathol 149:1575-1584.
20. Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S. 1997. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 20:38-43.
21. Labrecque S, Naor N, Thomson D, Matlashewski G. 1993. Analysis of the anti-p53 antibody response in cancer patients. Cancer Res 53:3468-3471.
22. Lauren P. 1965. The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type of carcinoma: an attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31-49.
23. Lin J-T, Wu M-S, Shun C-T, Lee W-J, Wang J-T, Wang T-H, Sheu J-C. 1995. Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages. Eur J Cancer 31:1879-1882.
24. Ming S-C. 1977. Gastric carcinoma: a pathobiological classification. Cancer 39:2475-2485.
25. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y. 1992. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1:229-233.
26. Mizutani T, Onda M, Tokunaga A, Yamanaka N, Sugisaki Y. 1993. Relationship of c-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 72:2083-2088.
27. Nakatani H, Sakamoto H, Yoshita T, Yokota J, Tahara E, Sugimura T, Terada M. 1990. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res 81:707-710.
28. Ogunbiyi OA, Goodfellow PJ, Herfarth K, Gagliardi G, Swanson PE, Birnbaum EH, Read TE, Fleshman JW, Kodner IJ, Moley JF. 1998. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427-433.
29. Okada K, Sugihara H, Bamba M, Bamba T, Hattori T. 2000. Sequential numerical changes of chromosomes 7 and 18 in diffuse-type stomach cancer cell lines: combined comparative genomic hybridization, fluorescence in situ hybridization, and ploidy analyses. Cancer Genet Cytogenet 118:99-107.
30. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA, Dyke DL. 1998. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer 21:333-339.
31. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo W-L, Chen C, Zhai Y, Dairkee SD, Ljung BM, Gray JW, Albertson DG. 1998. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20:207-211.
32. Powell SM, Petersen GNI, Krush AJ, Booker S, Jen J, Giardiello FM, Hamilton SR, Vogelstein B, Kinzler KW. 1993. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982-1987.
33. Renault B, van der Brock M, Fodde R, Wijnen J, Pellegata NS, Amadori D, Khan PM, Ranzani GN. 1993. Base transitions are the most frequent genetic changes at p53 in gastric cancer. Cancer Res 53:2614-2617.
34. Rhyu MG, Park WS, Jung YJ, Choi SW, Meltzer SJ. 1994. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 106:1584-1588.
35. Rooney PH, Murray GI, Stevenson DA, Haites NE, Cassidy J, McLeod HL. 1999. Comparative genomic hybridization and chromosomal instability in solid tumors. Br J Cancer 80:862-873.
36. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J. 1999. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24:299-305.
37. Sambrook J, Fritsch E, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
38. Sanz Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E, Sanz Esponera J, Merino MJ. 2000. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFR as prognostic factors in gastric cancer. Histol Histopathol 15:455-462.
39. Schmidt H, Wurl P, Taubert H, Meye A, Bache M, Holzhausen HJ, Hinze R. 1999. Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant. Genes Chromosomes Cancer 25:205-211.
40. Schmidt H, Taubert H, Meye A, Wurl P, Bache M, Bartel F, Holzhausen HJ, Hinze R. 2000. Gains in chromosomes 7, 8q, 15q, and 17q are characteristic changes in malignant but not in benign peripheral nerve sheath tumors from patients with Recklinghausen's disease. Cancer Lett 155:181-190.
41. Soman NR, Correa P, Ruiz BA, Wogan GN. 1991. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 88:4892-4896.
42. Tahara E. 1995. Molecular biology of gastric cancer. World J Surg 19:484-490.
43. Tamura G, Maesawa C, Suzuki Y, Ogasawara S, Terashima M, Saito K, Satodate R. 1993. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn J Cancer Res 84:1015-1018.
44. Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, Kobayashi M, Hirohashi S. 1993. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Cancer 72:3179-3184.
45. van Dekken H, Geelen E, Dinjens WN, Wijnhoven BP, Tilanus HW, Tanke HJ, Rosenberg C. 1999. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 59:748-752.
46. Vidgren V, Varis A, Kokkola A, Monni O, Puolakkainen P, Nordling S, Forozan F, Kallioniemi A, Vakkari M-L, Kivilaskso E, Knuutila S. 1999. Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer. Genes Chromosomes Cancer 24:24-29.
47. Whelan SL, Parkin DM, Masuyer E. 1993. Trends in cancer incidence and mortality. Lyon, France: IARC Scientific.
48. Wu C-W, Hsieh MC, Lo S-S, Lui W-Y, P'eng F-K. 1996a. Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg 183:201-207.
49. Wu C-W, Hsieh M-C, Lo S-S, Tsay S-H, Lui W-Y, P'eng F-K. 1996b. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut 38:525-527.
50. Wu C-W, Hsieh M-C, Lo S-S, Tsay S-H, Li A-F, Lui W-Y, P'eng F-K. 1997. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci 42:1265-1269.
51. Wu M-S, Lee C-W, Shun C-T, Wang H-P, Lee W-J, Sheu J-C, Lin J-T. 1998. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer. Cancer Res 58:1494-1497.
52. Wu M-S, Lee C-W, Shun C-T, Wang H-P, Lee W-J, Chang M-C, Sheu J-C, Lin J-T. 2000. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 27:403-411.
53. Yatsuoka T, Sunamura M, Furukawa T, Fukushige S, Yokoyama T, Inoue H, Shibuya K, Takeda K, Matsuno S, Horii A. 2000. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/7p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol 95:2080-2085.